期刊文献+

多时段血糖控制对糖尿病心血管病变转归的影响 被引量:1

ANALYSIS OF 2-YEAR FOLLOW-UP ON CARDIOVASCULAR DISEASE IN PATIENTS UNDER TEST AND CONTROL OF BLOOD GLUCOSE MORE THAN 6 TIMES IN ONE DAY
下载PDF
导出
摘要 目的:探讨多时段血糖控制对糖尿病心血管病变治疗上的作用。方法:对76例确诊2型糖尿病病人进行每月多时段血糖监测及根据结果进行降糖药物调整使血糖稳定,观察2年。对照组为35例根据空腹及早餐后血糖监测调整降糖药物。所有病人定期检查血糖、血压及糖化血红蛋白(HbA1c)、心电图、心脏B超、动态心电图(Holter)等。结果:糖尿病心血管病变发生或发展情况经过秩和检验,两组间结果比较差异有统计学意义(P<0.05)。结论:多时段血糖控制可延缓2型糖尿病心血管病变的发生并对心血管病变有改善作用。 Objective:To study the therapeutic effect multi-times/day control of blood glucose on treatment of diabetic cardiovascular disease. Methods:76 instances with type-2 diabetes(as experimental group) were treated with more than 6 points of blood glucose test and controlled in one day for each month, but the other 35 cases as control group were treated with 2 points of blood glucose test and controlled in a day morning each month. All patients were observed for 2 years,and regularly examined for urinary protein, blood glucose,blood pressure and HbAlc. Result: The numbers of onset and development of diabetic cardiovascular disease in the experimental group were higher than those in the control group. Conclusion: More than 6 points of blood glucose test and control will delay the onset and development of complication as well as improve the condition of diabetic cardiovascular disease of type 2 diabetes.
出处 《广西医科大学学报》 CAS 北大核心 2006年第4期549-551,共3页 Journal of Guangxi Medical University
基金 本研究获广西壮族自治区科技厅自然基金资助(合同号2002019)
关键词 糖尿病 心血管病变 多时段血糖监测与控制 diabetic cardiovascular disease the more point of blood glucose test and control in one day
  • 相关文献

参考文献7

  • 1贾伟平.血糖控制达标是预防糖尿病并发症的关键[J].上海医学,2005,28(1):1-3. 被引量:46
  • 2Fernandez-Real JM,Ricart W.Insulin Resistance and Cardiovascular Inflammatory Syndrome.Endocrine Reviews,2003,24(3):278-301.
  • 3Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus.N Engl J Med,1993,329(14):977-986.
  • 4UK Prospective Diabetes Study Group.Intensive blood glucose control with sulphony-ureas or insulin compared with conventional treatment and risk of complications in patient with type 2 diabetes (UKPDS33).Lancet,1998,352(9 131):837-853.
  • 5Stratton IM,Adler AI,Neil HA,et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35):prospective observational study.BMJ,2000,321 (7 258):405-412.
  • 6American Diabetes Association.Implications of the diabetes control and complications trial.Diabetes Care,2000,23 (Suppl1):24.
  • 7Kristian F.Hanssen KF.Blood Glucose Control and Microvascular and Macrovascular Complications in Diabetes.Diabetes,1997,46 (Suppl.2):101-103.

二级参考文献12

  • 1贾伟平,于浩泳,项坤三.胰岛素脉冲样分泌的意义及临床应用[J].中华内分泌代谢杂志,2004,20(4). 被引量:6
  • 2潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量:193
  • 3姜素英,左玉华,张和平,徐文,刘芳,贾伟平.社区糖尿病治疗达标现状分析[J].上海医学,2005,28(1):30-32. 被引量:31
  • 4卫生部疾病控制司 中华医学会糖尿病学分会.中国糖尿病防治指南[Z].,2003.4-6.
  • 5DCCT Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in IDDM. N Engl J Med, 1993, 329: 977-987.
  • 6The diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med, 2000,342:381- 389.
  • 7Nathan DM, l.achin J,Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med, 2003,348: 2294-2303.
  • 8UKPAD Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventiional treatment and risk of complications in patients with type 2 diabetes(UKPDS33). Lancet, 1998, 352:837-853.
  • 9Stevens RJ, Coleman RI., Adler AI, et al. Risk factors for myocardial infarction case falality and stroke case fatality in type 2 diabetes. Diabetes Care, 2004, 27: 201-207.
  • 10Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care, 1999, 22: 920-924.

共引文献45

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部